|
|
||||||||
a Department of Obstetrics and Gynecology, Rambam Medical Center, Faculty of Medicine, The Technion, Haifa, Israel;
b Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Hannover Medical School, Hannover, Germany;
c Robert Koch Institute, Berlin, Germany
Key Words. Embryonic stem cells • Murine leukemia virus • Feeder cells
Correspondence: Ulrich Martin, Ph.D., Leibniz Research Laboratories for Biotechnology and Artificial Organs (LEBAO), Podbielskistr. 380, 30659 Hannover, Germany. Telephone: 49-511-906-3533; Fax: 49-511-906-3569; e-mail: martin.ulrich{at}mh-hannover.de
Until recently, culture and expansion of nondifferentiated human embryonic stem cells (hESCs) depended on coculture with murine embryonic fibroblasts. Because mice are known to harbor a variety of pathogens, such culture conditions implicate the risk of xenozoonoses. Among these pathogens, endogenous retroviruses, including murine leukemia viruses (MuLVs), are of special importance. It is well known that some strains cause pathogenic (e.g., leukemic) effects and that xenotropic, polytropic, and amphotropic MuLVs are able to infect human cells.
In view of potential clinical applications of hESC lines, it is therefore imperative to investigate potential infection of hESCs by mouse feeder cellderived viruses. As a first step towards a comprehensive infection risk assessment, we have analyzed embryonic fibroblasts derived from different mouse strains for expression and release of xenotropic, polytropic, and amphotropic MuLVs. Moreover, several hESC lines have been investigated for expression of specific receptors for xenotropic/polytropic MuLVs, as well as for MuLV infection and expression.
Evidence for expression of humantropic MuLVs was found in cultures of mouse embryonic fibroblasts (MEFs). Moreover, expression of specific receptors for xenotropic/ polytropic MuLV on human HEK293 and hESC lines and infection after coculture with an MuLV-producing mink cell line could be demonstrated. In contrast, no evidence of MuLV transmission from MEFs to human HEK293 cells or to the hESC lines I-3, I-6, I-8, and H-9 has been obtained.
Our results suggest that recently established hESC lines are free of MuLV infections despite long-term close contact with MEFs.
This article has been cited by other articles:
![]() |
C. Unger, H. Skottman, P. Blomberg, M. Sirac Dilber, and O. Hovatta Good manufacturing practice and clinical-grade human embryonic stem cell lines Hum. Mol. Genet., April 15, 2008; 17(R1): R48 - R53. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hosseinkhani, H. Hosseinkhani, A. Khademhosseini, F. Bolland, H. Kobayashi, and S. P. Gonzalez Bone Morphogenetic Protein-4 Enhances Cardiomyocyte Differentiation of Cynomolgus Monkey ESCs in Knockout Serum Replacement Medium Stem Cells, March 1, 2007; 25(3): 571 - 580. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Koch, H. Siemen, A. Biegler, J. Itskovitz-Eldor, and O. Brustle Transduction of human embryonic stem cells by ecotropic retroviral vectors Nucleic Acids Res., October 6, 2006; 34(18): e120 - e120. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Gruen and L. Grabel Concise Review: Scientific and Ethical Roadblocks to Human Embryonic Stem Cell Therapy Stem Cells, October 1, 2006; 24(10): 2162 - 2169. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Schwanke, S. Wunderlich, M. Reppel, M. E. Winkler, M. Matzkies, S. Groos, J. Itskovitz-Eldor, A. R. Simon, J. Hescheler, A. Haverich, et al. Generation and Characterization of Functional Cardiomyocytes from Rhesus Monkey Embryonic Stem Cells Stem Cells, June 1, 2006; 24(6): 1423 - 1432. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
